Thane Wettig - 07 Aug 2023 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role: Chief Commercial Officer
Signature: /s/ Cecelia Monoarfa-Taime, Attorney-in-fact
Issuer symbol: FGEN
Transactions as of: 07 Aug 2023
Net transactions value: $0
Form type: 4
Filing time: 09 Aug 2023, 17:28:00 UTC
Previous filing: 26 Jun 2023
Next filing: 08 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FGEN	Common Stock	Award	$0	+200,000	+185%	$0.000000	308,261	07 Aug 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FGEN	Stock Option (Right to Buy)	Award	$0	+300,000		$0.000000	300,000	07 Aug 2023	Common Stock	300,000	$1.77	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the grant of Restricted Stock Units ("RSUs") that vest quarterly over 1 year from August 1, 2023, subject to the reporting person's continued service with the company on each such date.
F2	Twenty-Five percent of the shares subject to the option vest on August 7, 2024 and the remainder vest quarterly in equal installments over the following 3 years, subject to the reporting person's continued service with the company on each such date.